Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jimmy Huebert

Sports Medicine Tualatin, OR Medical Doctor

NPI 1225050834 CMS profile 55676

7654 Sw Mohawk St Bldg K, Ste 101, Tualatin, OR 97062

Open in the dashboard

General payments

$3,246

69 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jimmy Huebert of Tualatin, OR is reported in the CMS Open Payments database as having received $3,246 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,429 17
2024 General $424 16
2023 General $272 17
2022 General $916 12
2021 General $22 1
2020 General $44 2
2019 General $139 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jimmy Huebert
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Jimmy Huebert were reported at $1,429. Among 132 Sports Medicine profiles paid that year, the median was $99 and the middle half received between $33 and $256.

Show as a table
Year Jimmy Huebert Sports Medicine median Middle half National median
2019 $139 $131 $46–$324 $163
2020 $44 $96 $34–$276 $114
2021 $22 $120 $33–$421 $132
2022 $916 $107 $31–$274 $149
2023 $272 $63 $25–$180 $160
2024 $424 $104 $28–$282 $164
2025 $1,429 $99 $33–$256 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $2,041 46 payments
  2. SI-BONE, Inc. $937 7 payments
  3. Collegium Pharmaceutical, Inc. $51 3 payments
  4. Arteriocyte Medical Systems, Inc. $49 2 payments
  5. Kowa Pharmaceuticals America, Inc. $41 3 payments
  6. Vertex Pharmaceuticals Incorporated $25 1 payment
  7. Medline Industries, Inc. $18 1 payment
  8. Saluda Medical Americas, Inc. $16 1 payment
  9. Bioventus LLC $15 1 payment
  10. Nevro Corp. $15 1 payment
  11. Other $38 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,403 63 payments
  2. Travel and Lodging $1,092 5 payments
  3. Consulting Fee $750 1 payment
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $843 2 payments
  2. ENSITE PRECISION $576 2 payments
  3. PROCLAIM Structural Heart $566 4 payments
  4. PROCLAIM Neuromodulation $494 28 payments
  5. ETERNA Neuromodulation $131 2 payments
  6. ETERNA Structural Heart $96 1 payment
  7. PROCLAIM Structural Heart $86 6 payments
  8. PROCLAIM Structural Heart $65 2 payments
  9. SEGLENTIS $41 3 payments
  10. Nucynta $35 2 payments
  11. Other $126 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

145

Median for Sports Medicine: 144

Drug cost

$1,740

Median for Sports Medicine: $1,027

Branded share of claims

32.4%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 34 $747
Oxycodone Hcl Generic 69 $575
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $281
Methylprednisolone Generic 16 $99
Diazepam Generic 13 $38

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$65,097

Of which drugs: $1,729

Medicare patients

156

Average age 74

Services billed

2,186

88 women, 68 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 55%
Diabetes 19%
Depression 18%
Cancer 15%
Ischemic heart disease 13%
Chronic kidney disease 13%
Atrial fibrillation 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 42 256 $1,438
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 45 238 $183
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 44 621 $56
Injection, ropivacaine hydrochloride, 1 mg J2795 Office 55 458 $24

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record